Pre-existing antibiotic tolerance facilitates plasmid-mediated carbapenem resistance evolution in clinical Klebsiella pneumoniae
Antibiotic tolerance enables bacteria to survive bactericidal antibiotic exposure and has been linked to resistance evolution in laboratory systems and individual infections, but its role in plasmid-mediated resistance evolution in clinical populations remains unclear. Here, we analyzed a longitudinal collection of more than 800 clinical Klebsiella pneumoniae isolates spanning 1997-2020. Among…
A long-term study examining more than 800 clinical Klebsiella pneumoniae isolates from 1997 to 2020 has revealed a key mechanism behind the evolution of carbapenem resistance in these bacteria. Among the isolates, 17.6% displayed hidden ertapenem tolerance, a phenomenon where bacteria survive exposure to 30 times their specific ertapenem MIC.
This tolerance was mostly undetected and did not delay bacterial growth, yet it was more common in ertapenem-resistant strains. The presence of tolerance was noted even before the introduction of local ertapenem use and was more prevalent in strains with carbapenem resistance. Crucially, tolerant bacteria with pre-existing resistance plasmids were better able to acquire resistance plasmids, survive antibiotic exposure, and had an accelerated evolution of resistance to ceftazidime-avibactam.
Genetic analysis identified the uhpABC regulatory operon as a potential candidate linked to tolerance, and its coordinated expression enhanced ertapenem survival. In summary, the findings suggest that antibiotic tolerance, a hidden phenotype, can play a significant role in the evolution of carbapenem resistance in K. pneumoniae, highlighting the importance of understanding pre-existing bacterial characteristics in the context of antibiotic use and resistance evolution.
Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.